The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management


Por: Bordignon, S, Barra, S, Providencia, R, de Asmundis, C, Marijon, E, Farkowski, MM, Anic, A, Guerra, JM, Kosiuk, J, Iliodromitis, K, Schmidt, B, Conte, G, Chun, JK, Boveda, S

Publicada: 13 oct 2022 Ahead of Print: 1 ago 2022
Resumen:
The use of a blanking period (BP) after an atrial fibrillation (AF) ablation procedure is a common practice, but recent data questions the benign nature of early recurrences of atrial tachyarrhythmias (ERATs). A physician-based survey was carried out by the European Heart Rhythm Association (EHRA) to investigate the current definition and applicability of BP and ERAT management. An online questionnaire was sent to clinical and interventional electrophysiologists. A total of 436 respondents (88% interventional electrophysiologists) reported observing ERATs in 25% (interquartile range 15-35) of patients, less commonly in paroxysmal AF (PAF) compared with persistent AF (persAF). The median reported duration of BP used by respondents was 90 days, with 22% preferring a shorter BP duration for PAF patients compared with persAF. Half of the patients with ERATs are expected to also experience late recurrences (LR). Isolated episodes of ERATs are treated conservatively by 99% of the respondents, but repeat ablation during the BP is preferred by 20% of electrophysiologists for multiple ERATs and by 16% in patients with organized atrial tachyarrhythmias. In conclusion, ERATs are commonly observed after AF ablation, particularly in persAF patients, and are perceived as predictors of LR by half of the respondents. A general adherence to a 90-day BP duration was observed. During this time period, ERAT is mainly treated conservatively, but repeat ablation during the BP is occasionally offered to patients with multiple ERATs and those with organized atrial tachyarrhythmias.

Filiaciones:
Bordignon, S:
 Markuskrankenhaus, Cardioangiol Ctr Bethanien, Med Klin 3, D-60431 Frankfurt, Germany

Barra, S:
 Hosp Luz Arrabida, Cardiol Dept, P-4400 Vn Gaia, Portugal

 Royal Papworth Hosp NHS Fdn Trust, Cardiol Dept, Cambridge CB2 0AY, England

Providencia, R:
 Barts Hlth NHS Trust, Barts Heart Ctr, St Bartholomews Hosp, London EC1A 7BE, England

 UCL, Inst Hlth Informat, London NW1 2DA, England

de Asmundis, C:
 Vrije Univ Brussel, Heart Rhythm Management Ctr, Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium

Marijon, E:
 Univ Paris, F-75006 Paris, France

 Hop Europeen Georges Pompidou, Cardiol Dept, F-75015 Paris, France

 Hop Europeen Georges Pompidou, Paris Cardiovasc Res Ctr, F-75015 Paris, France

Farkowski, MM:
 Natl Inst Cardiol, Dept Heart Arrhythmia 2, Alpejska 42, PL-04628 Warsaw, Poland

Anic, A:
 Univ Hosp Ctr Split, Dept Cardiovasc Dis, Split 21000, Croatia

Guerra, JM:
 Univ Autonoma Barcelona, Dept Cardiol, Hosp Santa Creu & St Pau, CIBERCV, Barcelona 08025, Spain

Kosiuk, J:
 Helios Clin Kothen, Dept Rhythmol, D-06366 Kothen, Germany

Iliodromitis, K:
 Evangel Krankenhaus Hagen Haspe, Klin Kardiol & Rhythmol, D-58135 Hagen, Germany

Schmidt, B:
 Markuskrankenhaus, Cardioangiol Ctr Bethanien, Med Klin 3, D-60431 Frankfurt, Germany

Conte, G:
 Fdn Cardioctr Ticino, Cardiol Dept, CH-6900 Lugano, Switzerland

Chun, JK:
 Markuskrankenhaus, Cardioangiol Ctr Bethanien, Med Klin 3, D-60431 Frankfurt, Germany

Boveda, S:
 Vrije Univ Brussel, Heart Rhythm Management Ctr, Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium

 Clin Pasteur, Heart Rhythm Dept, F-31076 Toulouse, France

 INSERM, U970, F-75908 Paris, France
ISSN: 10995129
Editorial
OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 24 Número: 10
Páginas: 1684-1690
WOS Id: 000837520200001
ID de PubMed: 35942585
imagen Bronze

MÉTRICAS